Initially, it was thought that the active component in licorice was a steroid, glycyrrhetinic acid. It was presumed that this compound had direct mineralocorticoid activity. However, it now appears that the major action of glycyrrhetinic acid is to inhibit the enzyme 11 -hydroxysteroid dehydrogenase, thereby allowing cortisol to act as the major endogenous mineralocorticoid (3) (4) (5) . 11 -hydroxysteroid dehydrogenase promotes the conversion of cortisol to cortisone, and one form of this enzyme (11 -HSD2) is largely restricted in the kidney to the aldosterone-sensitive sites in the collecting tubules (5, 6 ). This effect is physiologically important, because cortisol binds as avidly as aldosterone to the mineralocorticoid receptor. Although cortisol has a much higher plasma concentration than aldosterone, it does not normally have much mineralocorticoid activity since it is locally converted to cortisone, a compound that does not bind to the mineralocorticoid receptor or to the collecting tubule glucocorticoid receptor which may also induce mineralocorticoid activity (6) .
The treatment of this syndrome varies with the cause. Cessation of licorice is effective in patients ingesting glycyrrhetinic acid. In comparison, a potassium-sparing diuretic such as spironolactone and a low salt diet should correct the abnormalities in the syndrome of apparent mineralocorticoid excess.
Although the source of the ingested licorice may not be obvious, it is present, for example, in some forms of flavored chewing gum and chewing tobacco. Recently, Ishiguchi et al reported that KM powder contains licorice which may induce this syndrome (2) . Actually, KM powder antacid is used as a digestant and contains 354 mg of licorice and 900 mg of sodium bicarbonate per 3.9 g of powder. Usual dosage for adult is 3.9 g per day, 3 times after meal. Therefore, physicians should pay attention to the long-term administration of KM powder in patients with gastrointestinal disorders. Especially when the patient is in the volume depletion, it may stimulate bicarbonate reabsorption in the proximal tubules, resulting in the development of metabolic alkalosis.
In the case report by Ishiguchi et al, the authors suggested that metabolic alkalosis and hypomanesemia may be responsible for the etiology of myoclonus (2) . However, there is no solid evidence for this. Symptomatic magnesium depletion is often associated with multiple biochemical abnormalities such as hypokalemia, hypocalcemia, and metabolic alkalosis. As a result, it is often difficult to ascribe specific clinical manifestations solely to hypomagnesemia. In 1960, 5 patients were reported with symptoms considered to be typical of magnesium depletion including tetany, positive Chvostek and Trousseau signs, and generalized convulsions (7). Somewhat similar findings such as generalized weakness, anorexia, hypokalemia, hypocalcemia, and positive Trousseau and Chvostek signs were noted when magnesium depletion was induced in normal volunteers (8) . Tetany can occur in the absence of hypocalcemia and alkalosis and is presumably due to lowering of the threshold for nerve stimulation (9) . Therefore, the causal relation between hypomagnesemia, metabolic alkalosis and myoclonus remain to be elucidated.
The diagnosis of metabolic alkalosis is usually evident from the history, as with vomiting, diuretic therapy, or diarrhea. In some cases, however, no cause is apparent. In this setting, the most likely diagnosis is surreptitious vomiting or diuretic therapy or one of the causes of mineralocorticoid excess (such as primary hyperaldosteronism, licorice induced mineralocorticoid excess syndrome). The first two disorders induce effective volume depletion, whereas hyperaldosteronism is usually associated with mild volume expansion due to the stimulatory effect of aldosterone on sodium reabsorption. See also p 59.
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